EXPE vs IPSC · P/E 20, rev $7.74B vs rev $109.2M
Expedia Group Inc. (EXPE) versus Century Therapeutics Inc (IPSC) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. IPSC currently screens at market cap $47.8M.
Not investment advice. Open the EXPE and IPSC stock pages for the full models.
Not investment advice.